| regulation of heart induction by regulation of canonical wnt signaling pathway | GO:0090081 | 1 | 0.280 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.246 | |
| cardiac cell fate determination | GO:0060913 | 3 | 0.241 | |
| nervous system development | GO:0007399 | 293 | 0.221 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.165 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.165 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.164 | |
| cell development | GO:0048468 | 328 | 0.157 | |
| organ formation | GO:0048645 | 3 | 0.156 | |
| transmembrane transport | GO:0055085 | 399 | 0.144 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.130 | |
| neuron fate commitment | GO:0048663 | 2 | 0.124 | |
| negative regulation of posttranscriptional gene silencing | GO:0060149 | 3 | 0.124 | |
| cation transport | GO:0006812 | 331 | 0.123 | |
| bmp signaling pathway involved in heart development | GO:0061312 | 3 | 0.121 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.114 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.109 | |
| organ morphogenesis | GO:0009887 | 147 | 0.107 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.105 | |
| cellular cation homeostasis | GO:0030003 | 163 | 0.104 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.103 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.101 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.098 | |
| extraocular skeletal muscle development | GO:0002074 | 1 | 0.097 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.097 | |
| generation of neurons | GO:0048699 | 152 | 0.096 | |
| post embryonic development | GO:0009791 | 2 | 0.095 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.093 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.092 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.092 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.091 | |
| specification of organ identity | GO:0010092 | 3 | 0.091 | |
| neuron differentiation | GO:0030182 | 138 | 0.089 | |
| cell morphogenesis | GO:0000902 | 296 | 0.087 | |
| amine metabolic process | GO:0009308 | 44 | 0.087 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.087 | |
| cardiovascular system development | GO:0072358 | 262 | 0.082 | |
| inorganic cation transmembrane transport | GO:0098662 | 194 | 0.082 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.082 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.081 | |
| system process | GO:0003008 | 349 | 0.080 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.079 | |
| positive regulation of transport | GO:0051050 | 336 | 0.079 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.076 | |
| ion homeostasis | GO:0050801 | 230 | 0.075 | |
| regulation of protein oligomerization | GO:0032459 | 26 | 0.074 | |
| neurogenesis | GO:0022008 | 169 | 0.071 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.070 | |
| cell cell signaling | GO:0007267 | 155 | 0.070 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.068 | |
| cation transmembrane transport | GO:0098655 | 238 | 0.068 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.068 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.067 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.067 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.067 | |
| cellular homeostasis | GO:0019725 | 196 | 0.066 | |
| regulation of methylation dependent chromatin silencing | GO:0090308 | 3 | 0.065 | |
| endodermal mesodermal cell signaling | GO:0003133 | 3 | 0.065 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.063 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.062 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.062 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.062 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.061 | |
| metal ion transport | GO:0030001 | 272 | 0.061 | |
| regulation of locomotion | GO:0040012 | 329 | 0.061 | |
| segmentation | GO:0035282 | 4 | 0.061 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.060 | |
| cell projection organization | GO:0030030 | 252 | 0.060 | |
| central nervous system development | GO:0007417 | 123 | 0.060 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.060 | |
| cellular calcium ion homeostasis | GO:0006874 | 117 | 0.060 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.059 | |
| cation homeostasis | GO:0055080 | 189 | 0.059 | |
| cell fate determination | GO:0001709 | 3 | 0.059 | |
| head development | GO:0060322 | 108 | 0.059 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.059 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.058 | |
| chemical homeostasis | GO:0048878 | 306 | 0.058 | |
| muscle contraction | GO:0006936 | 73 | 0.058 | |
| protein homooligomerization | GO:0051260 | 100 | 0.057 | |
| growth | GO:0040007 | 202 | 0.056 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.056 | |
| regulation of mitochondrion organization | GO:0010821 | 54 | 0.056 | |
| chromatin organization | GO:0006325 | 351 | 0.055 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.055 | |
| blood circulation | GO:0008015 | 113 | 0.055 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.054 | |
| muscle system process | GO:0003012 | 81 | 0.054 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 28 | 0.054 | |
| immune response | GO:0006955 | 307 | 0.054 | |
| regulation of cell motility | GO:2000145 | 299 | 0.052 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.052 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.052 | |
| protein oligomerization | GO:0051259 | 173 | 0.049 | |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.049 | |
| brain development | GO:0007420 | 97 | 0.049 | |
| protein processing | GO:0016485 | 226 | 0.048 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.048 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.048 | |
| hindbrain development | GO:0030902 | 3 | 0.048 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.048 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.047 | |
| inorganic ion transmembrane transport | GO:0098660 | 231 | 0.047 | |
| cardiac muscle cell contraction | GO:0086003 | 4 | 0.047 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.046 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.046 | |
| cellular metal ion homeostasis | GO:0006875 | 146 | 0.045 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.045 | |
| tube development | GO:0035295 | 125 | 0.045 | |
| neurological system process | GO:0050877 | 163 | 0.045 | |
| forebrain regionalization | GO:0021871 | 3 | 0.045 | |
| ion transmembrane transport | GO:0034220 | 338 | 0.044 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.044 | |
| menstrual cycle phase | GO:0022601 | 2 | 0.044 | |
| positive regulation of endopeptidase activity | GO:0010950 | 84 | 0.044 | |
| apoptotic mitochondrial changes | GO:0008637 | 57 | 0.044 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.043 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.043 | |
| nerve development | GO:0021675 | 4 | 0.043 | |
| calcium ion transport | GO:0006816 | 147 | 0.043 | |
| immune system development | GO:0002520 | 195 | 0.043 | |
| circulatory system development | GO:0072359 | 262 | 0.043 | |
| limbic system development | GO:0021761 | 3 | 0.043 | |
| mapk cascade | GO:0000165 | 288 | 0.043 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.042 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.042 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.042 | |
| regulation of acrosome reaction | GO:0060046 | 4 | 0.042 | |
| positive regulation of glucocorticoid secretion | GO:2000851 | 4 | 0.042 | |
| regulation of ion transport | GO:0043269 | 189 | 0.042 | |
| regulation of cell development | GO:0060284 | 161 | 0.041 | |
| digestive tract development | GO:0048565 | 75 | 0.041 | |
| protein maturation | GO:0051604 | 233 | 0.041 | |
| neuron projection development | GO:0031175 | 106 | 0.041 | |
| single organism cellular localization | GO:1902580 | 332 | 0.040 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.040 | |
| calcium ion homeostasis | GO:0055074 | 122 | 0.039 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.039 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.039 | |
| regulation of system process | GO:0044057 | 101 | 0.039 | |
| lipid metabolic process | GO:0006629 | 381 | 0.039 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.039 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.039 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.039 | |
| positive regulation of peptidase activity | GO:0010952 | 88 | 0.039 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.038 | |
| heart morphogenesis | GO:0003007 | 48 | 0.038 | |
| circulatory system process | GO:0003013 | 113 | 0.038 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.038 | |
| regulation of release of cytochrome c from mitochondria | GO:0090199 | 29 | 0.038 | |
| action potential | GO:0001508 | 34 | 0.038 | |
| chromatin modification | GO:0016568 | 298 | 0.038 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 200 | 0.038 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.037 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.037 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.037 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.037 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.037 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.037 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.037 | |
| heart process | GO:0003015 | 62 | 0.037 | |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001240 | 16 | 0.037 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.036 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.036 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.036 | |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.036 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.036 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.036 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.036 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.036 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.036 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.035 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 52 | 0.035 | |
| regulation of synaptic plasticity | GO:0048167 | 3 | 0.035 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.035 | |
| locomotory behavior | GO:0007626 | 1 | 0.035 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.034 | |
| spinal cord development | GO:0021510 | 4 | 0.034 | |
| regeneration | GO:0031099 | 4 | 0.034 | |
| regulation of protein localization | GO:0032880 | 296 | 0.034 | |
| neuron development | GO:0048666 | 113 | 0.034 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.034 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.034 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 4 | 0.034 | |
| protein localization to organelle | GO:0033365 | 280 | 0.034 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.033 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.033 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.033 | |
| single organism membrane organization | GO:0044802 | 268 | 0.033 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.033 | |
| thymus development | GO:0048538 | 3 | 0.033 | |
| epithelium development | GO:0060429 | 227 | 0.033 | |
| regulation of growth | GO:0040008 | 165 | 0.032 | |
| multi organism cellular process | GO:0044764 | 156 | 0.032 | |
| actin filament based movement | GO:0030048 | 17 | 0.032 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.032 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.032 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.032 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.032 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.031 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.031 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.031 | |
| response to hormone | GO:0009725 | 175 | 0.031 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.031 | |
| membrane organization | GO:0061024 | 292 | 0.031 | |
| cranial nerve development | GO:0021545 | 4 | 0.031 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.030 | |
| interspecies interaction between organisms | GO:0044419 | 156 | 0.030 | |
| heart formation | GO:0060914 | 2 | 0.030 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.030 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.030 | |
| endodermal cell fate commitment | GO:0001711 | 4 | 0.030 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.029 | |
| chemotaxis | GO:0006935 | 157 | 0.029 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.029 | |
| response to other organism | GO:0051707 | 261 | 0.029 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.029 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.029 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.029 | |
| modification of morphology or physiology of other organism | GO:0035821 | 43 | 0.028 | |
| negative regulation of gene silencing by mirna | GO:0060965 | 3 | 0.028 | |
| neuron projection morphogenesis | GO:0048812 | 50 | 0.028 | |
| regulation of cell migration | GO:0030334 | 289 | 0.028 | |
| purine containing compound biosynthetic process | GO:0072522 | 88 | 0.028 | |
| viral process | GO:0016032 | 146 | 0.028 | |
| right ventricular cardiac muscle tissue morphogenesis | GO:0003221 | 2 | 0.028 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 109 | 0.028 | |
| cell adhesion | GO:0007155 | 325 | 0.027 | |
| response to radiation | GO:0009314 | 151 | 0.027 | |
| positive regulation of axon extension | GO:0045773 | 4 | 0.027 | |
| regulation of ion homeostasis | GO:2000021 | 73 | 0.027 | |
| cell proliferation in forebrain | GO:0021846 | 1 | 0.027 | |
| immune effector process | GO:0002252 | 159 | 0.027 | |
| dephosphorylation | GO:0016311 | 209 | 0.027 | |
| actin filament based process | GO:0030029 | 224 | 0.027 | |
| positive regulation of insulin like growth factor receptor signaling pathway | GO:0043568 | 4 | 0.027 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.027 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.027 | |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.027 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.027 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.027 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.027 | |
| response to virus | GO:0009615 | 126 | 0.026 | |
| heart development | GO:0007507 | 95 | 0.026 | |
| negative regulation of gene silencing by rna | GO:0060967 | 3 | 0.026 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.026 | |
| positive regulation of acrosome reaction | GO:2000344 | 4 | 0.026 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.026 | |
| secretion by cell | GO:0032940 | 226 | 0.026 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.026 | |
| forebrain development | GO:0030900 | 26 | 0.026 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.026 | |
| hair follicle morphogenesis | GO:0031069 | 2 | 0.026 | |
| actin mediated cell contraction | GO:0070252 | 12 | 0.026 | |
| multicellular organismal signaling | GO:0035637 | 34 | 0.026 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.026 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.026 | |
| glial cell migration | GO:0008347 | 4 | 0.026 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 57 | 0.026 | |
| behavior | GO:0007610 | 112 | 0.026 | |
| artery smooth muscle contraction | GO:0014824 | 3 | 0.026 | |
| regulation of immune response | GO:0050776 | 201 | 0.026 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.026 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.025 | |
| release of cytochrome c from mitochondria | GO:0001836 | 35 | 0.025 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.025 | |
| cell differentiation in spinal cord | GO:0021515 | 1 | 0.025 | |
| defense response to virus | GO:0051607 | 71 | 0.025 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.025 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 25 | 0.025 | |
| reproductive process | GO:0022414 | 106 | 0.025 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.025 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.025 | |
| mitochondrial transport | GO:0006839 | 60 | 0.025 | |
| positive regulation of mitochondrion organization | GO:0010822 | 30 | 0.025 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 89 | 0.025 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.025 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.024 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.024 | |
| tube morphogenesis | GO:0035239 | 95 | 0.024 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.024 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.024 | |
| heart contraction | GO:0060047 | 62 | 0.024 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.024 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.024 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.024 | |
| blood vessel development | GO:0001568 | 172 | 0.024 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.024 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.024 | |
| response to wounding | GO:0009611 | 168 | 0.023 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.023 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.023 | |
| cerebellum development | GO:0021549 | 2 | 0.023 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.023 | |
| photoreceptor cell differentiation | GO:0046530 | 2 | 0.023 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.023 | |
| protein catabolic process | GO:0030163 | 325 | 0.023 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.023 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.023 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 4 | 0.023 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.023 | |
| lymphocyte activation | GO:0046649 | 133 | 0.023 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.022 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.022 | |
| female gamete generation | GO:0007292 | 2 | 0.022 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 3 | 0.022 | |
| regulation of protein transport | GO:0051223 | 213 | 0.022 | |
| regulation of heart contraction | GO:0008016 | 50 | 0.022 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.022 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 49 | 0.022 | |
| regulation of protein processing | GO:0070613 | 150 | 0.022 | |
| response to lipid | GO:0033993 | 206 | 0.022 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.022 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.022 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.022 | |
| regulation of male gonad development | GO:2000018 | 4 | 0.022 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.022 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.022 | |
| regulation of heart rate | GO:0002027 | 38 | 0.022 | |
| pituitary gland development | GO:0021983 | 2 | 0.022 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.022 | |
| positive regulation of response to external stimulus | GO:0032103 | 88 | 0.022 | |
| luteinizing hormone secretion | GO:0032275 | 1 | 0.022 | |
| metencephalon development | GO:0022037 | 2 | 0.022 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.021 | |
| inner ear morphogenesis | GO:0042472 | 4 | 0.021 | |
| intracellular protein transport | GO:0006886 | 270 | 0.021 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.021 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.021 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 109 | 0.021 | |
| mating | GO:0007618 | 1 | 0.021 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.021 | |
| organophosphate biosynthetic process | GO:0090407 | 163 | 0.021 | |
| kidney development | GO:0001822 | 53 | 0.021 | |
| taxis | GO:0042330 | 157 | 0.021 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.021 | |
| response to hypoxia | GO:0001666 | 96 | 0.021 | |
| somitogenesis | GO:0001756 | 2 | 0.021 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 3 | 0.021 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.021 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.021 | |
| mammary gland morphogenesis | GO:0060443 | 2 | 0.021 | |
| defense response | GO:0006952 | 315 | 0.020 | |
| oogenesis | GO:0048477 | 2 | 0.020 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.020 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.020 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.020 | |
| pattern specification process | GO:0007389 | 43 | 0.020 | |
| purine nucleotide biosynthetic process | GO:0006164 | 84 | 0.020 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.020 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.020 | |
| cardiac muscle contraction | GO:0060048 | 34 | 0.020 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.020 | |
| globus pallidus development | GO:0021759 | 1 | 0.020 | |
| protein ubiquitination | GO:0016567 | 314 | 0.020 | |
| forebrain dorsal ventral pattern formation | GO:0021798 | 1 | 0.020 | |
| positive regulation of protein complex assembly | GO:0031334 | 86 | 0.020 | |
| behavioral defense response | GO:0002209 | 0 | 0.020 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.020 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.020 | |
| neural tube patterning | GO:0021532 | 2 | 0.020 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.020 | |
| associative learning | GO:0008306 | 1 | 0.020 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.020 | |
| angiogenesis | GO:0001525 | 147 | 0.020 | |
| cell growth | GO:0016049 | 160 | 0.020 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.020 | |
| synaptic transmission | GO:0007268 | 61 | 0.020 | |
| epidermis morphogenesis | GO:0048730 | 3 | 0.020 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.019 | |
| sequestering of calcium ion | GO:0051208 | 17 | 0.019 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.019 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.019 | |
| cellular response to external stimulus | GO:0071496 | 111 | 0.019 | |
| regulation of blood circulation | GO:1903522 | 59 | 0.019 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.019 | |
| regulation of organ formation | GO:0003156 | 4 | 0.019 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.019 | |
| nucleotide biosynthetic process | GO:0009165 | 109 | 0.019 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.019 | |
| neural tube formation | GO:0001841 | 3 | 0.019 | |
| ribose phosphate biosynthetic process | GO:0046390 | 82 | 0.019 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.019 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.019 | |
| embryo development | GO:0009790 | 123 | 0.019 | |
| amide transport | GO:0042886 | 76 | 0.019 | |
| organ induction | GO:0001759 | 4 | 0.018 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 40 | 0.018 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.018 | |
| regulation of cell growth | GO:0001558 | 135 | 0.018 | |
| negative regulation of growth | GO:0045926 | 97 | 0.018 | |
| regulation of secretion | GO:0051046 | 194 | 0.018 | |
| response to axon injury | GO:0048678 | 1 | 0.018 | |
| protein localization to membrane | GO:0072657 | 160 | 0.018 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.018 | |
| mitochondrial membrane organization | GO:0007006 | 40 | 0.018 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.018 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.018 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.018 | |
| regulation of glial cell differentiation | GO:0045685 | 3 | 0.018 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.018 | |
| peptidyl serine modification | GO:0018209 | 106 | 0.018 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.018 | |
| oxidation reduction process | GO:0055114 | 396 | 0.017 | |
| plasma membrane organization | GO:0007009 | 115 | 0.017 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.017 | |
| response to oxygen levels | GO:0070482 | 100 | 0.017 | |
| single organism reproductive process | GO:0044702 | 98 | 0.017 | |
| vasculature development | GO:0001944 | 181 | 0.017 | |
| circadian behavior | GO:0048512 | 2 | 0.017 | |
| gland development | GO:0048732 | 48 | 0.017 | |
| regulation of membrane permeability | GO:0090559 | 25 | 0.017 | |
| hemopoiesis | GO:0030097 | 180 | 0.017 | |
| spermatid differentiation | GO:0048515 | 4 | 0.017 | |
| ribonucleotide biosynthetic process | GO:0009260 | 81 | 0.017 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.017 | |
| endodermal mesodermal cell signaling involved in heart induction | GO:0003134 | 3 | 0.017 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.017 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.017 | |
| rhythmic behavior | GO:0007622 | 2 | 0.017 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.017 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.017 | |
| regulation of neuron differentiation | GO:0045664 | 70 | 0.017 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.017 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.017 | |
| memory | GO:0007613 | 3 | 0.017 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.017 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 79 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.016 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 20 | 0.016 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.016 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.016 | |
| endomembrane system organization | GO:0010256 | 196 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.016 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.016 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.016 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 2 | 0.016 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 102 | 0.016 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.016 | |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.016 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.016 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.016 | |
| neuron apoptotic process | GO:0051402 | 39 | 0.016 | |
| positive regulation of multi organism process | GO:0043902 | 56 | 0.016 | |
| zymogen activation | GO:0031638 | 70 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.016 | |
| heart field specification | GO:0003128 | 2 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.016 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.016 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.016 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.016 | |
| peptide metabolic process | GO:0006518 | 51 | 0.016 | |
| neurotransmitter secretion | GO:0007269 | 4 | 0.016 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.016 | |
| axonogenesis | GO:0007409 | 31 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| defense response to other organism | GO:0098542 | 129 | 0.015 | |
| renal system development | GO:0072001 | 63 | 0.015 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.015 | |
| positive regulation of release of cytochrome c from mitochondria | GO:0090200 | 18 | 0.015 | |
| tissue regeneration | GO:0042246 | 3 | 0.015 | |
| detection of chemical stimulus involved in sensory perception of smell | GO:0050911 | 2 | 0.015 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.015 | |
| cell division | GO:0051301 | 168 | 0.015 | |
| tonic smooth muscle contraction | GO:0014820 | 3 | 0.015 | |
| rna processing | GO:0006396 | 255 | 0.015 | |
| cell activation | GO:0001775 | 213 | 0.015 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.015 | |
| regulation of protein stability | GO:0031647 | 87 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.015 | |
| maintenance of location | GO:0051235 | 112 | 0.015 | |
| response to drug | GO:0042493 | 81 | 0.015 | |
| cellular potassium ion transport | GO:0071804 | 60 | 0.015 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.015 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.015 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.015 | |
| execution phase of apoptosis | GO:0097194 | 32 | 0.015 | |
